Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2020 Filed Mar 2, 2020 23:34 UTC |
FRY JOHN ADirector
|
GrantRestricted Stock Units · Derivative | 34,483 | $4.93 Strike: $0.00 | $170,001.19 |
DisclosureSEC source: 0001209191-20-014729 · doc4.xml · derivative · entry 7 FRY JOHN A · CIK 0001255140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,483 Underlying: Common Stock · 34,483 shares Expires 2030-02-28 F1 · price: The security converts to common stock on a one-to-one basis. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:34 UTC |
FRY JOHN ADirector
|
Exercise / conversionRestricted Stock Units · Derivative | 11,356 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014729 · doc4.xml · derivative · entry 6 FRY JOHN A · CIK 0001255140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,712 Underlying: Common Stock · 11,356 shares Expires 2029-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:34 UTC |
FRY JOHN ADirector
|
Exercise / conversionRestricted Stock Units · Derivative | 12,373 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014729 · doc4.xml · derivative · entry 5 FRY JOHN A · CIK 0001255140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,372 Underlying: Common Stock · 12,373 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:34 UTC |
FRY JOHN ADirector
|
Exercise / conversionRestricted Stock Units · Derivative | 6,166 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014729 · doc4.xml · derivative · entry 4 FRY JOHN A · CIK 0001255140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,166 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:34 UTC |
FRY JOHN ADirector
|
Exercise / conversionCommon Stock | 11,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014729 · doc4.xml · nonDerivative · entry 3 FRY JOHN A · CIK 0001255140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,908 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:34 UTC |
FRY JOHN ADirector
|
Exercise / conversionCommon Stock | 12,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014729 · doc4.xml · nonDerivative · entry 2 FRY JOHN A · CIK 0001255140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,552 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:34 UTC |
FRY JOHN ADirector
|
Exercise / conversionCommon Stock | 6,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014729 · doc4.xml · nonDerivative · entry 1 FRY JOHN A · CIK 0001255140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:33 UTC |
Fordham Benjamin CEVP and General Counsel
|
Disposition to issuerPerformance Based Restricted · Derivative | 20,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014726 · doc4.xml · derivative · entry 5 Fordham Benjamin C · CIK 0001700942 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires not disclosed F4 · derivative.exercise_date: The vesting of these performance-based restricted shares was subject to the Issuer's attainment of certain performance objectives between 1/1/2017 and 12/31/2019. These performance objectives were not attained so the restricted shares have been forfeited. F4 · derivative.expiration_date: The vesting of these performance-based restricted shares was subject to the Issuer's attainment of certain performance objectives between 1/1/2017 and 12/31/2019. These performance objectives were not attained so the restricted shares have been forfeited. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:33 UTC |
Fordham Benjamin CEVP and General Counsel
|
GrantStock Options (Right to Buy) · Derivative | 26,250 | $0.00 Strike: $4.93 | $0.00 |
DisclosureSEC source: 0001209191-20-014726 · doc4.xml · derivative · entry 4 Fordham Benjamin C · CIK 0001700942 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,250 Underlying: Common Stock · 26,250 shares Expires 2031-02-28 F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:33 UTC |
Fordham Benjamin CEVP and General Counsel
|
GrantPerformance Based Restricted · Derivative | 52,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014726 · doc4.xml · derivative · entry 3 Fordham Benjamin C · CIK 0001700942 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,500 Underlying: Common Stock · 52,500 shares Expires not disclosed F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2020-2022 Performance Period. F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2020-2022 Performance Period. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:33 UTC |
Fordham Benjamin CEVP and General Counsel
|
Tax withholdingCommon Stock | 10,659 | $4.93 | $52,548.87 |
DisclosureSEC source: 0001209191-20-014726 · doc4.xml · nonDerivative · entry 2 Fordham Benjamin C · CIK 0001700942 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,007 Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:33 UTC |
Fordham Benjamin CEVP and General Counsel
|
GrantCommon Stock | 26,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014726 · doc4.xml · nonDerivative · entry 1 Fordham Benjamin C · CIK 0001700942 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,666 F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:42 UTC |
Williams Hubert JamesDirector
|
GrantRestricted Stock Units · Derivative | 34,483 | $4.93 Strike: $0.00 | $170,001.19 |
DisclosureSEC source: 0001209191-20-014744 · doc4.xml · derivative · entry 7 Williams Hubert James · CIK 0001659816 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,483 Underlying: Common Stock · 34,483 shares Expires 2030-02-28 F1 · price: The security converts to common stock on a one-to-one basis. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Based on the Reporting Peron's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of the Common Stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:42 UTC |
Williams Hubert JamesDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 11,356 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014744 · doc4.xml · derivative · entry 6 Williams Hubert James · CIK 0001659816 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,712 Underlying: Common Stock · 11,356 shares Expires 2029-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:42 UTC |
Williams Hubert JamesDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 12,373 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014744 · doc4.xml · derivative · entry 5 Williams Hubert James · CIK 0001659816 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,372 Underlying: Common Stock · 12,373 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:42 UTC |
Williams Hubert JamesDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 6,166 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014744 · doc4.xml · derivative · entry 4 Williams Hubert James · CIK 0001659816 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,166 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:42 UTC |
Williams Hubert JamesDirector
|
Exercise / conversionCommon Stock | 11,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014744 · doc4.xml · nonDerivative · entry 3 Williams Hubert James · CIK 0001659816 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:42 UTC |
Williams Hubert JamesDirector
|
Exercise / conversionCommon Stock | 12,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014744 · doc4.xml · nonDerivative · entry 2 Williams Hubert James · CIK 0001659816 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:42 UTC |
Williams Hubert JamesDirector
|
Exercise / conversionCommon Stock | 6,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014744 · doc4.xml · nonDerivative · entry 1 Williams Hubert James · CIK 0001659816 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:42 UTC |
SMITH WAYNE TDirector · Chairman & CEO
|
Disposition to issuerPerformance Based Restricted · Derivative | 75,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014743 · doc4.xml · derivative · entry 7 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,000 shares Expires not disclosed F4 · derivative.exercise_date: The vesting of these performance-based restricted shares was subject to the Issuer's attainment of certain performance objectives between 1/1/2017 and 12/31/2019. These performance objectives were not attained so the restricted shares have been forfeited. F4 · derivative.expiration_date: The vesting of these performance-based restricted shares was subject to the Issuer's attainment of certain performance objectives between 1/1/2017 and 12/31/2019. These performance objectives were not attained so the restricted shares have been forfeited. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:42 UTC |
SMITH WAYNE TDirector · Chairman & CEO
|
GrantStock Options (Right to Buy) · Derivative | 112,500 | $0.00 Strike: $4.93 | $0.00 |
DisclosureSEC source: 0001209191-20-014743 · doc4.xml · derivative · entry 6 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,500 Underlying: Common Stock · 112,500 shares Expires 2031-02-28 F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:42 UTC |
SMITH WAYNE TDirector · Chairman & CEO
|
GrantPerformance Based Restricted · Derivative | 225,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014743 · doc4.xml · derivative · entry 5 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires not disclosed F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2020-2022 Performance Period. F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2020-2022 Performance Period. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:42 UTC |
SMITH WAYNE TDirector · Chairman & CEO
|
Tax withholdingCommon Stock | 33,941 | $4.93 | $167,329.13 |
DisclosureSEC source: 0001209191-20-014743 · doc4.xml · nonDerivative · entry 2 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,915,041 Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:42 UTC |
SMITH WAYNE TDirector · Chairman & CEO
|
GrantCommon Stock | 112,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014743 · doc4.xml · nonDerivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,948,982 F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:41 UTC |
Simon Lynn TPresident and CMO
|
Disposition to issuerPerformance Based Restricted · Derivative | 20,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014742 · doc4.xml · derivative · entry 5 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires not disclosed F4 · derivative.exercise_date: The vesting of these performance-based restricted shares was subject to the Issuer's attainment of certain performance objectives between 1/1/2017 and 12/31/2019. These performance objectives were not attained so the restricted shares have been forfeited. F4 · derivative.expiration_date: The vesting of these performance-based restricted shares was subject to the Issuer's attainment of certain performance objectives between 1/1/2017 and 12/31/2019. These performance objectives were not attained so the restricted shares have been forfeited. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:41 UTC |
Simon Lynn TPresident and CMO
|
GrantStock Options (Right to Buy) · Derivative | 26,250 | $0.00 Strike: $4.93 | $0.00 |
DisclosureSEC source: 0001209191-20-014742 · doc4.xml · derivative · entry 4 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,250 Underlying: Common Stock · 26,250 shares Expires 2031-02-28 F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:41 UTC |
Simon Lynn TPresident and CMO
|
GrantPerformance Based Restricted · Derivative | 52,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014742 · doc4.xml · derivative · entry 3 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,500 Underlying: Common Stock · 52,500 shares Expires not disclosed F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2020-2022 Performance Period. F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2020-2022 Performance Period. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:41 UTC |
Simon Lynn TPresident and CMO
|
Tax withholdingCommon Stock | 10,659 | $4.93 | $52,548.87 |
DisclosureSEC source: 0001209191-20-014742 · doc4.xml · nonDerivative · entry 2 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,452 Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:41 UTC |
Simon Lynn TPresident and CMO
|
GrantCommon Stock | 26,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014742 · doc4.xml · nonDerivative · entry 1 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,111 F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:39 UTC |
Krishnan K RangaDirector
|
GrantRestricted Stock Units · Derivative | 34,483 | $4.93 Strike: $0.00 | $170,001.19 |
DisclosureSEC source: 0001209191-20-014740 · doc4.xml · derivative · entry 5 Krishnan K Ranga · CIK 0001724829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,483 Underlying: Common Stock · 34,483 shares Expires 2030-02-28 F1 · price: The security converts to common stock on a one-to-one basis. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Based on the Reporting Peron's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of the Common Stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:39 UTC |
Krishnan K RangaDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 11,356 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014740 · doc4.xml · derivative · entry 4 Krishnan K Ranga · CIK 0001724829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,712 Underlying: Common Stock · 11,356 shares Expires 2029-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:39 UTC |
Krishnan K RangaDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 12,373 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014740 · doc4.xml · derivative · entry 3 Krishnan K Ranga · CIK 0001724829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,372 Underlying: Common Stock · 12,373 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:39 UTC |
Krishnan K RangaDirector
|
Exercise / conversionCommon Stock | 11,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014740 · doc4.xml · nonDerivative · entry 2 Krishnan K Ranga · CIK 0001724829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:39 UTC |
Krishnan K RangaDirector
|
Exercise / conversionCommon Stock | 12,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014740 · doc4.xml · nonDerivative · entry 1 Krishnan K Ranga · CIK 0001724829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,746 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:38 UTC |
Johnson Jason KSVP & CAO
|
GrantStock Options (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $4.93 | $0.00 |
DisclosureSEC source: 0001209191-20-014739 · doc4.xml · derivative · entry 4 Johnson Jason K · CIK 0001798438 · SVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-02-28 F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:38 UTC |
Johnson Jason KSVP & CAO
|
GrantPerformance Based Restricted · Derivative | 15,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014739 · doc4.xml · derivative · entry 3 Johnson Jason K · CIK 0001798438 · SVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires not disclosed F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2020-2022 Performance Period. F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2020-2022 Performance Period. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:38 UTC |
Johnson Jason KSVP & CAO
|
Tax withholdingCommon Stock | 2,809 | $4.93 | $13,848.37 |
DisclosureSEC source: 0001209191-20-014739 · doc4.xml · nonDerivative · entry 2 Johnson Jason K · CIK 0001798438 · SVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,651 Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:38 UTC |
Johnson Jason KSVP & CAO
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014739 · doc4.xml · nonDerivative · entry 1 Johnson Jason K · CIK 0001798438 · SVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,460 F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:37 UTC |
JENNINGS WILLIAM NORRISDirector
|
GrantRestricted Stock Units · Derivative | 34,483 | $4.93 Strike: $0.00 | $170,001.19 |
DisclosureSEC source: 0001209191-20-014738 · doc4.xml · derivative · entry 7 JENNINGS WILLIAM NORRIS · CIK 0001435225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,483 Underlying: Common Stock · 34,483 shares Expires 2030-02-28 F1 · price: The security converts to common stock on a one-to-one basis. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Based on the Reporting Peron's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of the Common Stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:37 UTC |
JENNINGS WILLIAM NORRISDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 11,356 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014738 · doc4.xml · derivative · entry 6 JENNINGS WILLIAM NORRIS · CIK 0001435225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,712 Underlying: Common Stock · 11,356 shares Expires 2029-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:37 UTC |
JENNINGS WILLIAM NORRISDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 12,373 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014738 · doc4.xml · derivative · entry 5 JENNINGS WILLIAM NORRIS · CIK 0001435225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,372 Underlying: Common Stock · 12,373 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:37 UTC |
JENNINGS WILLIAM NORRISDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 6,166 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014738 · doc4.xml · derivative · entry 4 JENNINGS WILLIAM NORRIS · CIK 0001435225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,166 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:37 UTC |
JENNINGS WILLIAM NORRISDirector
|
Exercise / conversionCommon Stock | 11,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014738 · doc4.xml · nonDerivative · entry 3 JENNINGS WILLIAM NORRIS · CIK 0001435225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,384 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:37 UTC |
JENNINGS WILLIAM NORRISDirector
|
Exercise / conversionCommon Stock | 12,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014738 · doc4.xml · nonDerivative · entry 2 JENNINGS WILLIAM NORRIS · CIK 0001435225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,028 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:37 UTC |
JENNINGS WILLIAM NORRISDirector
|
Exercise / conversionCommon Stock | 6,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014738 · doc4.xml · nonDerivative · entry 1 JENNINGS WILLIAM NORRIS · CIK 0001435225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,655 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:36 UTC |
Hirsch Elizabeth TDirector
|
GrantRestricted Stock Units · Derivative | 34,483 | $4.93 Strike: $0.00 | $170,001.19 |
DisclosureSEC source: 0001209191-20-014736 · doc4.xml · derivative · entry 3 Hirsch Elizabeth T · CIK 0001508503 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,483 Underlying: Common Stock · 34,483 shares Expires 2030-02-28 F1 · price: The security converts to common stock on a one-to-one basis. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Based on the Reporting Peron's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of the Common Stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:36 UTC |
Hirsch Elizabeth TDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 11,356 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014736 · doc4.xml · derivative · entry 2 Hirsch Elizabeth T · CIK 0001508503 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,712 Underlying: Common Stock · 11,356 shares Expires 2029-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:36 UTC |
Hirsch Elizabeth TDirector
|
Exercise / conversionCommon Stock | 11,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014736 · doc4.xml · nonDerivative · entry 1 Hirsch Elizabeth T · CIK 0001508503 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,356 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:35 UTC |
Hingtgen TimDirector · President and COO
|
Disposition to issuerPerformance Based Restricted · Derivative | 37,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014733 · doc4.xml · derivative · entry 5 Hingtgen Tim · CIK 0001598637 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,500 shares Expires not disclosed F4 · derivative.exercise_date: The vesting of these performance-based restricted shares was subject to the Issuer's attainment of certain performance objectives between 1/1/2017 and 12/31/2019. These performance objectives were not attained so the restricted shares have been forfeited. F4 · derivative.expiration_date: The vesting of these performance-based restricted shares was subject to the Issuer's attainment of certain performance objectives between 1/1/2017 and 12/31/2019. These performance objectives were not attained so the restricted shares have been forfeited. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:35 UTC |
Hingtgen TimDirector · President and COO
|
GrantStock Options (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $4.93 | $0.00 |
DisclosureSEC source: 0001209191-20-014733 · doc4.xml · derivative · entry 4 Hingtgen Tim · CIK 0001598637 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2031-02-28 F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.